Open AccessP1031: LOW‐DOSE DOACS IN VERY HIGH‐RISK MYELOPROLIFERATIVE NEOPLASMS: LESS BLEEDING BUT MORE ARTERIAL THROMBOTIC EVENTS
Author(s) -
Herbreteau L.,
Papageorgiou L.,
Le Clech L.,
Garcia G.,
James C.,
PanPetesch B.,
Couturaud F.,
Lippert E.,
Gerotziafas G.,
Ianotto J.C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846992.75907.c1
Subject(s) - apixaban , medicine , rivaroxaban , thrombosis , incidence (geometry) , atrial fibrillation , cohort , warfarin , physics , optics